Yüklüyor......
New drugs in acute myeloid leukemia
The standard therapy for acute myeloid leukemia (AML) has not changed meaningfully for the past four decades. Improvements in supportive care and modifications to the dose and schedule of existing agents have led to steady improvements in outcomes. However, developing new therapies for AML has been...
Kaydedildi:
| Yayımlandı: | Ann Oncol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4843183/ https://ncbi.nlm.nih.gov/pubmed/26802152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw015 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|